{
  "ticker": "LLY",
  "target_date": "2025-07-02",
  "actual_date": "2025-07-02",
  "collected_at": "2025-12-08T11:57:55.113941",
  "price": {
    "open": 773.66,
    "high": 776.99,
    "low": 765.19,
    "close": 776.431884765625,
    "volume": 1978300,
    "change_1d_pct": 0.44,
    "change_7d_pct": 1.12,
    "change_30d_pct": 3.2
  },
  "technicals": {
    "rsi_14": 38.77,
    "sma_20": 782.89,
    "sma_50": 776.99,
    "macd": 3.349,
    "macd_signal": 4.892,
    "macd_histogram": -1.543,
    "bb_upper": 817.51,
    "bb_lower": 748.26,
    "price_vs_sma20_pct": -0.82,
    "price_vs_sma50_pct": -0.07,
    "volume_ratio": 0.63
  },
  "fundamentals": {
    "market_cap": 893027811328,
    "pe_ratio": 48.80818,
    "forward_pe": 43.961826,
    "price_to_book": 37.506588,
    "price_to_sales": 15.029129,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.42,
    "pct_from_52w_low": 59.7
  },
  "macro": {
    "spy": {
      "price": 618.73,
      "change_1d_pct": 0.45,
      "change_7d_pct": 2.25
    },
    "vix": {
      "level": 16.64,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.29
    },
    "dollar_index": {
      "level": 96.78
    },
    "gold": {
      "price": 3348.0
    },
    "regime": "BULL_LOW_VOL"
  },
  "news": [
    {
      "headline": "NYLI Winslow Large Cap Growth Fund Q1 2025 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1751499000,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f555296355d4c2b39401f981100486b0e3aac83cd9a6706de47d93ce4af7559b"
    },
    {
      "headline": "Wall Street Bulls Look Optimistic About Lilly (LLY): Should You Buy?",
      "source": "Yahoo",
      "datetime": 1751463003,
      "summary": "The average brokerage recommendation (ABR) for Lilly (LLY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
      "url": "https://finnhub.io/api/news?id=98e83eefe91e73f7289104f4b4d28bc18faf408ec7568d72c1ffc003b766f36d"
    },
    {
      "headline": "Will AbbVie's Acquisition Spree Aid Pipeline Growth?",
      "source": "Yahoo",
      "datetime": 1751460360,
      "summary": "ABBV's $2.1 billion Capstan deal and 20+ recent acquisitions sharpen its pipeline edge across immunology and beyond.",
      "url": "https://finnhub.io/api/news?id=323e3788c281ffd783e10e7ffb52dc8e71c27b8c917a971f6f8edbeb356d1644"
    },
    {
      "headline": "Hims & Hers: The Bubble Implosion Looks Far From Over (Downgrade)",
      "source": "SeekingAlpha",
      "datetime": 1751459400,
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a3678000cae0270a50d50d5933f2507a62627851b95a0e8f5cc669ba3ff108f8"
    },
    {
      "headline": "Semaglutide Market Forecast Report 2025-2033 | Growth Accelerates Amid Rising Awareness, Regulatory Approvals, and Strong Pipeline Advancements",
      "source": "Yahoo",
      "datetime": 1751449380,
      "summary": "The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the market for semaglutide, a GLP-1 receptor agonist, is growing due to its efficacy in glycemic control ",
      "url": "https://finnhub.io/api/news?id=cacaeab5a9d58cf9cbe3fc3c6cccefcd299e1467220dd1cf04e9ee6d8b3b85ad"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199300.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000176/xslF345X05/wk-form4_1750199300.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750199159.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000174/xslF345X05/wk-form4_1750199159.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198988.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000172/xslF345X05/wk-form4_1750198988.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198711.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000170/xslF345X05/wk-form4_1750198711.xml"
    },
    {
      "form": "4",
      "date": "2025-06-17",
      "description": "xslF345X05/wk-form4_1750198504.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000168/xslF345X05/wk-form4_1750198504.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}